Cancer immunotherapy research holds great promise for better understanding various cancer types, as well as infectious disease, and immunodeficiencies. As the field evolves to clinical research, more sophisticated and standardized culturing tools are required. Specifically, raw material traceability, therapeutic-grade media endorsed by regulatory bodies, and documentation become increasingly important.
Thermo Fisher Scientific provides a portfolio of products for Cancer Immunotherapy research —designed for the efficient isolation, activation, and culture of various types of immune cells. These products are manufactured in compliance with ISO 9001and ISO13485 standards. Products are supplied with a certificate of analysis, origin, and access to authorization letters for our Drug Master Files (DMF).
Step-by-step guide to immunotherapy research products
Isolate specific cancer immunological cells from whole blood. The DynaMag CTS and Dynabeads D3/CD28 CTS are approved for research use or for manufacturing cell-, gene-, or tissue-based products
Activate isolated immune cell types with Dynabeads CD3/CD28 CTS and efficiently transfect with the Neon Transfection system.
Expand your cancer immunotherapy cells cells with AIM V CTS, OpTmizer CTS, and DPBS CTS media. All are fully-defined, xeno-free, serum-free, and cGMP-quality media for your peace of mind when entering the clinic. AIM V CTS is available as a therapeutic-grade medium and is intended for human ex vivo tissue and cell culture processing applications
Characterize cell populations to ensure purity. The Invitrogen Attune NxT Flow Cytometer and the 5500 Series Genetic Analysis Systems provide the sensitivity to detect rare and precious events.Resources
Brochure
Literature
For Research Use Only. Not for use in diagnostic procedures.